Published in
American Society of Clinical Oncology, Journal of Clinical Oncology, 15_suppl(36), p. e21220-e21220
DOI: 10.1200/jco.2018.36.15_suppl.e21220
Links
Tools
Risk of not receiving 2nd line therapy is high in EGFR mt+ pts: Real world data of certified lung cancer centers on treatment sequence in EGFR mt+ pts.
Journal article published in 2018 by
Julia Roeper,
Markus Falk,
Markus Tiemann,
Claas Wesseler 
,
Gunther Wiest,
Sandra Sackmann,
Dieter Ukena,
Lukas Heukamp,
Frank Griesinger
,
Gunther Wiest,
Sandra Sackmann,
Dieter Ukena,
Lukas Heukamp,
Frank Griesinger
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 